In response to government mandates attacking the drug counterfeit epidemic, Pfizer has digitized its supply chain and is realizing significant efficiency improvements.
The Pharmaceutical industry has been plagued by the realities of counterfeit medicines being introduced into their complex supply chains for decades. With increasing threats to patient lives and brand credibility, companies are looking for innovative solutions. The rise of digitalization, and specifically blockchain technology, gives new hope for solving Big Pharma’s global supply chain issue.
A digitized supply chain in pharma has unfortunately failed to mitigate the growing opioid crisis in America. Can it and will it?
Novartis is a digital pioneer in developed countries, but has struggled to increase patient access in developing countries. How can Novartis use digital technologies as a catalyst to redesign fragmented distribution systems?
How government mandated drug traceability is transforming healthcare supply chains
Counterfeit drugs adversely impact both consumers and pharmaceutical companies. Can blockchain help solve this problem?